Bacterin Announces Earnings Release and Conference Call Date for 2012 Fourth Quarter & Year End Results
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and coatings for
medical applications, today announced that it will release its financial
results for the period ended December 31, 2012, after the close of U.S.
financial markets on March 26, 2013.
An accompanying conference call hosted by Guy Cook, Chief Executive
Officer, and John Gandolfo, Chief Financial Officer, to discuss results
will be held at 10:00 a.m. ET, on Wednesday, March 27, 2013. Please
refer to the information below for conference call dial-in information
and webcast registration.
|
Conference dial-in:
|
|
|
|
877-269-7756
|
|
International dial-in:
|
|
|
|
201-689-7817
|
|
Conference Name:
|
|
|
|
Bacterin’s 2012 Fourth Quarter & Year End Results Conference Call
|
|
Webcast Registration:
|
|
|
|
Click
Here
|
|
|
|
|
|
|
Following the live call, a replay will be available on the Company's
website, www.bacterin.com,
under “Investor Info".
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops,
manufactures and markets biologics products to domestic and
international markets. Bacterin's proprietary methods optimize the
growth factors in human allografts to create the ideal stem cell
scaffold to promote bone, subchondral repair and dermal growth. These
products are used in a variety of applications including enhancing
fusion in spine surgery, relief of back pain, promotion of bone growth
in foot and ankle surgery, promotion of cranial healing following
neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division develops, employs, and licenses
bioactive coatings for various medical device applications. For further
information, please visit www.bacterin.com
